Medscape2d
AstraZeneca Sues Generic Drugmakers, Claims Cancer Drug Patent Violations
AstraZeneca is asking a court to immediately stop generic drugmakers from their plans to make and sell generic forms of ...
Tax Guru3d
Budget 2025: Exempting specific drugs supplied under Patient Assistance Programs by leading pharmaceutical companies
Budget 2025: Seeks to further amend notification No. 16/2017-Customs, dated the 20th April, 2017 so to exempt certain drugs for supply under Patient Assistance Programme run by specified ...
Budget 2025: Pfizer, Novartis, AstraZeneca to benefit from BCD exemptions; pharma stocks mixed
Select listed pharma player including Pfizer, Novartis India, AstraZeneca Pharma and GSK Pharma shall be the beneficiaries of ...
Oneindia4d
Budget 2025: Life-saving Medications for Cancer and Chronic Conditions Made More Affordable, Check Full List
The Union Budget 2025-26 introduces key healthcare measures, including the exemption of 36 life-saving drugs from Basic ...
The Straits Times7d
AstraZeneca, Daiichi’s drug cleared for wider use in breast cancer patients in US
An AstraZeneca and Daiichi Sankyo drug designed to replace chemotherapy was cleared by US regulators for broader use in late-stage breast cancer patients. The Food and Drug Administration ...
Business Today3d
Budget 2025: Pfizer, Novartis, AstraZeneca to benefit from BCD exemptions; pharma stocks mixed
According to the list released by the Ministry of Finance, Five drugs from AstraZeneca Pharma India's kitty- Selumetinib, Benralizumab, Fulvestrant, Acalabrutinib, Olaparib have been exempted ...